ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:11 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 1001
Drug details and screening numbers
Drug Name: AICAR
Drug ID: 1001
Synonyms: N1-(b-D-Ribofuranosyl)-5-aminoimidazole-4-carboxamide
Brand name: AICAR
Target: AAPK1 (AMPK) agonist
Number of cell lines screened: 840
Screening concentration range(s): 7.8125 to 2000 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a292 |
gain_cnaPANCAN273 |
1001 |
1 |
1 |
AICAR |
AAPK1 (AMPK) agonist |
33 |
804 |
7.6 |
7.77 |
8.52 |
0.743 |
0.57 . |
0.57 . |
0.49 |
2.18e-04 |
4.47e-40 |
4.61e-01 |
12 |
All-tests volcano plot